Captopril Therapy in Dilated Cardiomyopathy in Childhood [Turk Kardiyol Dern Ars]
Turk Kardiyol Dern Ars. 1993; 21(4): 226-232

Captopril Therapy in Dilated Cardiomyopathy in Childhood

M.Filiz ŞENOCAK1, Muhsin SARAÇLAR1, Süheyla ÖZKUTLU1

In childhood dilated cardiomyopathy (CMP) which causes congestive heart failure with deterioration of the left ventricular functions, angiotensin converting enzyme (ACE) inhibitors have not been in routine usage. Despite a good experience of more than 10 years with adult patients, there is still paucity of data in the English literature regarding the use of ACE inhibitors in children with dilated CMP. In our study, we used captopril in 19 digitalized children with dilated CMP who were admitted to the Hacettepe University Pediatric Cardiology Department and studied for a period of 2 days-16 months (mean 8.2 months). Clinical, laboratory and echocardiographic results showed that catopril usage in a mean daily dose of 1.8 mg/kg for longer than 2 or 3 months led to improvement of left compared to baseline values, those obtained after the fifth month, the average ejection fraction rose from 31 % to 60 % (p<0.001) and fractional shortening from 14.5 % to 32.3 % (p<0.001). It is emphazised that children with dilated CMP would benefit from the routine use of captopril.

Keywords: Dilated cardiomyopathy, captopril

How to cite this article
M.Filiz ŞENOCAK, Muhsin SARAÇLAR, Süheyla ÖZKUTLU. Captopril Therapy in Dilated Cardiomyopathy in Childhood. Turk Kardiyol Dern Ars. 1993; 21(4): 226-232
© Copyright 2019 Archives of the Turkish Society of Cardiology
LookUs & Online Makale